Aim To assess (i) the association between lipoprotein(a) [Lp(a)] with the likelihood of coronary heart disease and metabolic syndrome (MS) and (ii) its covariates in Turkish adults.
Introduction
Lipoprotein(a) [Lp(a)] is a low-density lipoprotein (LDL)-like substance with a specific apoprotein, apoprotein(a), bound to apo B100 by disulfide bridges, and its concentrations show considerable variation in normal, healthy individuals and are under strong genetic control [1] . Lp(a) is poorly influenced either by dietary measures or by hypolipidemic drugs [2] . It has a similarity to plasminogen and is also structurally related to LDL [3] . These structural similarities between Lp(a) and both LDL and plasminogen strengthen the possibility of its role in atherogenesis. Numerous studies have suggested that serum Lp(a) concentration carries an independent risk factor for coronary heart disease (CHD) [4] . However, the molecular mechanism by which Lp(a) might promote atherosclerosis has not been clarified. Nearly 90% of Lp(a) variation is controlled by the gene locus encoding the apo(a) protein, and it was recognized that ethnic differences might be an important element of its level. In an earlier study, higher Lp(a) did not seem to be associated with CHD in African-Americans [5] . Furthermore, the relationship of Lp(a) concentrations with insulin resistance (IR) and other components of metabolic syndrome (MS) remains controversial, and needs to be studied especially in different ethnic groups. A Turkish adult population sample exhibiting a high prevalence of MS [6] appeared suitable for such an investigation. Hence, the purpose of this basically crosssectional analysis is to examine the association of plasma Lp(a) levels with CHD and the relation of these levels with MS and its components among male and female participants of the Turkish Adult Risk Factor Study.
Population and methods

Population sample
The Turkish Adult Risk Factor Study is a prospective survey on the prevalence of cardiac disease and risk factors in adults in Turkey carried out periodically almost biennially since 1990 in 59 communities scattered throughout all geographical regions of the country [7] . It involves a random sample of the Turkish adult population, representatively stratified for sex, age,
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geographical regions, and for rural-urban distribution [7] . Measurements of plasma Lp(a) were first performed at the follow-up visit in 2003/04 in 660 and in 2005/06 in 868 participants, making a total of 1528 measurements in 1309 persons (608 men and 701 women), 33 years of age or older. The survey conformed to the principles embodied in the Declaration of Helsinki and was approved by the Istanbul University Ethics Committee. Individuals of the cohort were visited in their addresses on the eve of the examination and were requested to give written consent for participation after having read an explanatory note, which manifested by their voluntary participation the next morning. Data were obtained by history of the past years through a questionnaire, physical examination of the cardiovascular system, sampling of blood, and recording of a resting electrocardiogram.
Measurements of risk variables
Blood pressure was measured in the sitting position on the right arm, and the mean of two recordings at least 3 min apart was recorded. Waist circumference was measured with a tape (Roche LI95 63B 00; Roche Diagnostics, Mannheim, Germany), the participant standing and wearing only underwear, at the level midway between the lower rib margin and the iliac crest.
Blood samples were collected, spun at 1000 g for 10 min and shipped within a few hours on cooled gel packs at 2-51C to Istanbul to be stored in deep-freeze at -751C, until analyzed at the Yildiz Technical University in the same city. Concentrations of serum Lp(a) were measured only in fasting sera by Behring kits and Behring nephelometry (Behring Diagnostics, Marburg, Germany). Serum concentrations of total cholesterol, fasting triacylglycerols, glucose, and high-density lipoprotein cholesterol (HDL-C and second generation, directly without precipitation) were determined using enzymatic kits from Roche Diagnostics with a Hitachi 902 autoanalyzer (Roche Diagnostics). LDL cholesterol values were computed according to the Friedewald formula. Concentrations of insulin were determined (in 77% of participants) by the chemiluminescent immunometric method using Roche kits and an Elecsys 1010 immunautoanalyzer (Roche Diagnostics). Serum g-glutamyltransferase (GGT) activity was assayed by the kinetic method using Glucana as substrate (Thermo Trace, Noble Park, Victoria, Australia) with an Hitachi 902 autoanalyzer.
Definitions and outcomes
Individuals with MS were identified when three out of the five criteria of the National Cholesterol Education Program (ATP III) [8] were met, modified for prediabetes (fasting glucose 100-125 mg/dl) [9] and further for abdominal obesity using as cutpoint Z 95 cm in men, as recently assessed in the Turkish Adult Risk Factor study [10] . Homeostatic model assessment (HOMA) was calculated with the following formula: [11] insulin (mIU/l) Â glucose (in mmol/l)/22.5. Insulin resistance (HOMA-IR) was defined as an index greater than 2.1, a cutoff that represented the 73rd percentile in nondiabetic adults of the Turkish Adult Risk Factor Study. Values of the baseline examination were used to evaluate prospective developments.
Diagnosis of nonfatal CHD was based on the presence of angina pectoris, of a history of myocardial infarction with or without accompanying Minnesota codes of the ECG [12] , or on a history of myocardial revascularization. Among women, typical angina and age above 45 years were prerequisite for a definitive diagnosis when angina was isolated. ECG changes of 'ischemic type' of greater than minor degree (Codes 1.1-2, 4.1-2, 5.1-2, 7.1) were considered as myocardial infarct sequelae or myocardial ischemia, respectively. During a 2.1-year follow-up, 28 individuals were ascertained as dead, and 1092 were routinely reexamined. The 1380 person-years of follow-up yielded eight incident cardiovascular disease deaths and 16 nonfatal CHD which, along with those having CHD at baseline, resulted in a total of 179 participants with fatal or nonfatal CHD (13.1%).
Data analysis
Sex-specific tertiles of Lp(a) values were formed by cutpoints of 5.2 and 15.7 mg/dl in men and of 4.82 and 18.43 mg/dl in women. The following number of adults were comprised in tertiles I-III: 433, 446, 430. Descriptive parameters were shown as mean ± standard deviation, or as adjusted estimated mean ± standard error and in percentages. Owing to the skewed distribution, logtransformed (geometric) values were used for Lp(a), insulin, HOMA, GGT, and C-reactive protein. Two-sided t-tests and Pearson's w 2 tests were used to analyze the differences in means and proportions between groups. After exclusion of the cohort with the dependent variable at baseline examination, estimates [and 95% confidence intervals (CI)] for the odds ratio (OR) of a dependent variable were obtained by use of logistic regression analyses in models that controlled for potential confounders. A P value of less than 0.05 on the two-sided test was considered statistically significant. Statistical analyses were performed using SPSS-10 for Windows (SPSS Inc., Chicago, Illinois, USA, Nr. 9026510).
Results
The sample population consisted of 608 men and 701 women. The median (interquartile range) serum Lp(a) values were 9.23 (3.85; 19.75) mg/dl in men and 11.4 (4.81; 24.4) mg/dl in women. Five and 95 percentile values were 1.60; 52.2 mg/dl in men and 2.02; 57.8 in women. Men had 19% lower Lp(a) levels than women (P = 0.003). In participants with two measurements 2 years apart, values had a high correlation (r = 0.76, P = 0.0005), and the later measurements were only 4% higher (P = 0.40).
Clinical 'characteristics of the sample population' (mean age 56.8 ± 11.3 years) are given in Table 1 separately for sexes. Tendency to central obesity, high concentrations of triglycerides, low mean levels of LDL cholesterol, and of HDL-C compared with western populations are apparent. In this middle-aged and elderly population, women, mostly postmenopausal, disclosed significantly higher levels than men in most risk variables.
Lipoprotein(a) levels, coronary heart disease likelihood and independence from metabolic syndrome/insulin resistance Logistic regression analysis for the association of Lp(a) concentrations with CHD likelihood was made basically after adjustment for sex, age, and smoking status. Table 2 shows that Lp(a) was associated significantly with prevalent CHD in both sexes combined [OR: 1.53 (95% CI: 1.06; 2.20)] and at a borderline significance in women. Two further models were analyzed by adding either MS or HOMA-IR. The adjustment for MS as well led to no change whatsoever in the association of Lp(a) among men and marginally increased the OR in women to become significant [OR: 1.67 (95% CI: 1.014; 2.75)].
This was consistent with a full independence in both sexes of the associations of Lp(a) with CHD from MS (which in turn was significantly associated with CHD).
When in Model 3 MS was substituted by HOMA-IR, both Lp(a) and HOMA-IR lost significance in men suggesting the two variables mediated each other. By contrast in women, although HOMA-IR was not associated with CHD, Lp(a) concentrations exhibited a higher OR [2.30 (95% CI: 1.17; 4.53)] for CHD as compared with and without MS, thus indicating that the association with CHD in women was independent of HOMA-IR.
Correlates of lipoprotein(a)
Lp(a) was not significantly correlated with fasting insulin (missing values in 4% of sample) in men (r = -0.06, P = 0.17), nor in women (r = -0.05, P = 0.17). Lp(a) was not significantly correlated with GGT (missing values in 21% of sample) in men (r = 0.01, P = 0.47), but was inversely correlated in women (r = -0.15, P < 0.001). Correlations between Lp(a) and HDL-C (r = 0.04, P > 0.2) or fasting glucose (r = -0.03, P > 0.2) were not significant. A linear regression analysis for Lp(a) concentrations in a model comprising sex, age, total cholesterol, triglycerides, insulin, waist circumference, systolic blood pressure, and GGT revealed in men total cholesterol as significant and waist circumference as borderline significant covariates (Table 3 ). In women, only GGT was an independent significant covariate. This corresponded to a 11.3% increase in Lp(a) for halving of GGT levels in women, or to a 9-10% increase in Lp(a) for a decrement of 10 cm waist girth in men.
Inverse association of the lipoprotein(a) mid-tertile with metabolic syndrome and dyslipidemia
Cross tabulation of the prevalence of MS in the Lp(a) tertiles showed significantly lower MS prevalence in the mid-tertile (30.6 vs. 36.1% in the bottom tertile, P = 0.014) in sexes combined.
Sex-specific tertiles of Lp(a) were analyzed by logistic regression for an association with MS, adjusted for age and sex ( (Table 5 ). Although sex-adjusted and age-adjusted HDL-C values were similar across the Lp(a) tertiles, triglyceride concentrations were significantly lower in the midtertile than in the bottom (by 14%) or in the top tertile (by 10%). This constellation suggests the involvement of an inverse interaction of Lp(a) with triglycerides along with one between insulin and Lp(a), and is consistent with insulin inhibiting the generation of Lp(a) in a subset actually classified predominantly in the mid-tertile of Lp(a) by which potentially higher Lp(a) and lower triglyceride levels and MS partly get classified in the mid-tertile.
Discussion
This population-based study in middle-aged and elderly adults showed that Lp(a) was a significant determinant of CHD likelihood in women and in both sexes combined, an association that was independent from MS and, in women, from IR. The magnitude of this association in women is at least 1.29-fold (95% CI: 1.01; 1.66) for a fivefold increment of Lp(a) levels. For a similar increment, the association with CHD likelihood in men was not strong enough (OR: 1.20) to attain significance, irrespective of a presence of MS or IR. Serum Lp(a) concentrations displayed little interindividual variance; total cholesterol and, in women, GGT were independent correlates of elevated plasma Lp(a). The mid-tertile of Lp(a) (roughly 5-17 mg/dl) was significantly and inversely associated with serum triglycerides and (presumably) thus with MS, an association independent of central obesity in women.
In earlier studies that investigated Lp(a) levels in the Turkish population [13] [14] [15] [16] the enzyme-linked immunosorbent assay method was utilized. Mean values were lowest in the Turkish Heart Study conducted on 800 men and women (11.2 and 14.7 mg/dl, respectively) [13] . Several smaller studies [14] [15] [16] reported slightly higher mean concentrations. Top, middle, and bottom third mean values in the meta-analysis of the studies conducted worldwide were 100, 20, and 5 mg/dl [4] . The limits between tertiles of the this study were 17 and 5 mg/dl indicating by one-third overall lower values compared with findings of the mentioned meta-analysis.
Lipoprotein(a) and associations with metabolic syndrome and components
On the basis of OR elicited, a five-fold increase in Lp(a) levels across the mid-tertile may be estimated to protect Turkish adults from MS by about 25%. The interaction of Lp(a) with MS and its components is complicated. The relation of insulin levels to Lp(a) levels has been controversial. In one study, Lp(a) levels were lower in participants with hyperinsulinemia [17] , but not in other studies [18, 19] . In a small study [20] in which apo(a) phenotypes were measured, Lp(a) levels were significantly related to IR (negative correlation) but not to insulin concentrations. Although we found no significant association between insulin concentrations and Lp(a) level on linear analysis, and although the link of Lp(a) to CHD in women was independent of HOMA-IR, our analysis by tertiles suggested an inverse interaction between insulin and Lp(a) which might be mediated by the apo(a) gene. Rainwater and Haffner [21] demonstrated that insulin and 2-h glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. They also showed that Lp(a) density (size) is significantly related to particle sizes of both HDL and LDL. Having not examined the LPA genotype, we cannot confirm this observation but our data on the relationship between MS concentrations of Lp(a) are consistent with it, and may be interpreted as such that low levels (< 5 mg/dl) are associated positively with MS, inter-mediary levels with significantly reduced MS likelihood in both sexes, although the presumably inadequate number of MS in participants with high levels, though tending to exhibit reduced likelihood, resulted in underpowered findings. Distribution of LPA genotype and Lp(a) isoform size might well be different in participants with low or high levels of Lp(a). Collectively, these observations are consistent with insulin inhibiting the generation of Lp(a) in a subset of the sample.
Lp(a) displays size heterogeneity which is genetically determined. Independent of this relation to MS, a significant association with CHD likelihood existed in women that was independent of HOMA-IR as well. The magnitude of the association is similar to or slightly stronger than the CHD risk found in the meta-analysis of 18 prospective studies; a reported 1.7 relative risk across upper and lower tertiles [20-fold Lp(a) levels] corresponds, namely, to a 1.14-fold risk for an increment of five-fold spread of Lp(a) values. This study, in which a seemingly HOMA-IR-mediated and insignificant CHD likelihood appeared in men, may be underpowered to detect the risk association for individual sexes.
Lp(a) has been detected in the vessel wall, where it seems to be retained more avidly than LDL [22] . Lp(a) has been shown to be critical in the initiation of atherogenesis through induction of chemotactic activity to circulating monocytes [23] and enhancement of expression of intercellular adhesion molecule-1 [24] . Recent clinical studies provided support for the hypothesis that Lp(a) attenuates fibrinolysis and promotes coagulation [25, 26] . Women might be more prone to the prothrombotic potential of elevated Lp(a) levels.
Covariates of serum lipoprotein(a) levels
Cited among factors that influence plasma Lp(a) levels positively are age, sex, LDL and total cholesterol, and inversely body mass index, triglycerides and in men insulin and waist-to-hip ratio [27] [28] [29] . The association between total cholesterol and Lp(a) in this study is not surprising, as Lp(a) is structurally related to LDL.
Confirming our earlier analysis [28] , Lp(a) levels were in inverse association with serum GGT in women. Waist circumference, a component of MS, was shown to be a major determinant of serum GGT activity among Turkish adults [30] . Although Lp(a) has no independent association with serum GGT in men, an inverse association exists in women independent of waist girth or insulin levels, the reason for which is unclear.
This study implicates that intermediary Lp(a) concentrations, although by themselves appearing 'innocent', when accompanied by the presence of MS, could accelerate progression of vascular disease especially in women, as each factor contributed independently to CHD likelihood.
The lack of availability of LPA genotype and Lp(a) isoform size in this study limits to delineate better the relationship between MS and IR on the one hand and Lp(a) concentrations on the other. Evaluation of Lp(a) levels on the basis of single assays by the Behring nephelometry might be considered as a minor limitation, however, the high degree of consistency and little systematic bias between repeat measurements 2 years apart in as large as one-sixth of the study sample indicates little intraindividual variability in comparison with the large interindividual variation.
To conclude, serum Lp(a) is a significant determinant of CHD likelihood among Turkish women independent of both MS and IR. For a five-fold increment of Lp(a) levels, a 30% excess CHD may be anticipated. The CHD likelihood in men is insignificant and mediated by HOMA-IR. Not across the whole range of Lp(a) values but the mid-tertile is inversely associated with serum triglycerides and thereby with MS in Turkish adults, this being independent of central obesity in women. The inverse association requires genetic exploring whether an inhibition of the apo(a) gene by hyperinsulinemia may be underlying.
